These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 12369607)

  • 41. Long-term efficacy and safety of milnacipran compared to clomipramine in patients with major depression.
    Leinonen E; Lepola U; Koponen H; Mehtonen OP; Rimon R
    Acta Psychiatr Scand; 1997 Dec; 96(6):497-504. PubMed ID: 9421348
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Expanding psychopharmacologic treatment options for the depressed medical patient.
    Stoudemire A
    Psychosomatics; 1995; 36(2):S19-26. PubMed ID: 7724709
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy of antidepressants in the treatment of severe depression: the place of mirtazapine.
    Kasper S
    J Clin Psychopharmacol; 1997 Apr; 17 Suppl 1():19S-28S. PubMed ID: 9090574
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tolerability and safety of fluvoxamine and other antidepressants.
    Westenberg HG; Sandner C
    Int J Clin Pract; 2006 Apr; 60(4):482-91. PubMed ID: 16620364
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tolerability and safety aspects of mirtazapine.
    Nutt DJ
    Hum Psychopharmacol; 2002 Jun; 17 Suppl 1():S37-41. PubMed ID: 12404669
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Achieving remission from depression with venlafaxine and venlafaxine extended release: a literature review of comparative studies with selective serotonin reuptake inhibitors.
    Rudolph RL
    Acta Psychiatr Scand Suppl; 2002; (415):24-30. PubMed ID: 12492770
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nefazodone. A review of its pharmacology and clinical efficacy in the management of major depression.
    Davis R; Whittington R; Bryson HM
    Drugs; 1997 Apr; 53(4):608-36. PubMed ID: 9098663
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mirtazapine: a review of its use in major depression.
    Holm KJ; Markham A
    Drugs; 1999 Apr; 57(4):607-31. PubMed ID: 10235695
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Clinically relevant drug interactions with new generation antidepressants and antipsychotics].
    Eckert A
    Ther Umsch; 2009 Jun; 66(6):485-92. PubMed ID: 19496045
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Neuronal and immunological basis of action of antidepressants in chronic pain - clinical and experimental studies.
    Mika J; Zychowska M; Makuch W; Rojewska E; Przewlocka B
    Pharmacol Rep; 2013; 65(6):1611-21. PubMed ID: 24553009
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Selective serotonin reuptake inhibitors: a review of efficacy and tolerability in depression.
    Mace S; Taylor D
    Expert Opin Pharmacother; 2000 Jul; 1(5):917-33. PubMed ID: 11249500
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Venlafaxine. A review of its pharmacology and therapeutic potential in depression.
    Holliday SM; Benfield P
    Drugs; 1995 Feb; 49(2):280-94. PubMed ID: 7729333
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficacy in long-term treatment of depression.
    Montgomery SA
    J Clin Psychiatry; 1996; 57 Suppl 2():24-30. PubMed ID: 8626360
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Are the newer antidepressant drugs as effective as established physical treatments? Results from an Australasian clinical panel review.
    Parker G; Mitchell P; Wilhelm K; Menkes D; Snowdon J; Schweitzer I; Grounds D; Skerritt P; Roy K; Hadzi-Pavlovic D
    Aust N Z J Psychiatry; 1999 Dec; 33(6):874-81. PubMed ID: 10619215
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Trends in the development of new antidepressants. Is there a light at the end of the tunnel?
    Pacher P; Kecskemeti V
    Curr Med Chem; 2004 Apr; 11(7):925-43. PubMed ID: 15078174
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mirtazapine: pharmacology in relation to adverse effects.
    Nutt D
    Acta Psychiatr Scand Suppl; 1997; 391():31-7. PubMed ID: 9265949
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacokinetics of milnacipran in comparison with other antidepressants.
    Puozzo C; Leonard BE
    Int Clin Psychopharmacol; 1996 Sep; 11 Suppl 4():15-27. PubMed ID: 8923123
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Milnacipran: a unique antidepressant?
    Kasper S; Pail G
    Neuropsychiatr Dis Treat; 2010 Sep; 6(Suppl I):23-31. PubMed ID: 20856597
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Milnacipran, a new specific serotonin and noradrenaline reuptake inhibitor.
    Boyer P; Briley M
    Drugs Today (Barc); 1998 Aug; 34(8):709-20. PubMed ID: 14988777
    [TBL] [Abstract][Full Text] [Related]  

  • 60. No benefit from flexible titration above minimum licensed dose in prescribing antidepressants for major depression: systematic review.
    Furukawa TA; Salanti G; Cowen PJ; Leucht S; Cipriani A
    Acta Psychiatr Scand; 2020 May; 141(5):401-409. PubMed ID: 31891415
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.